Amplify Alternative Harvest ETF (MJ)
| Assets | $105.36M |
| Expense Ratio | 0.76% |
| PE Ratio | 16.86 |
| Shares Out | 5.62M |
| Dividend (ttm) | $1.00 |
| Dividend Yield | 5.30% |
| Ex-Dividend Date | Dec 30, 2024 |
| Payout Frequency | n/a |
| Payout Ratio | 89.28% |
| Volume | 63,363 |
| Open | 18.83 |
| Previous Close | 18.80 |
| Day's Range | 18.64 - 19.02 |
| 52-Week Low | 16.12 |
| 52-Week High | 45.42 |
| Beta | 1.20 |
| Holdings | 13 |
| Inception Date | Dec 2, 2015 |
About MJ
Fund Home PageThe Amplify Alternative Harvest ETF (MJ) is an exchange-traded fund that is based on the Prime Alternative Harvest index. The fund tracks an index of global firms engaged in the legal cultivation, production, marketing or distribution of cannabis, cannabinoids or tobacco products. The portfolio is weighted by market cap or equally based on a proprietary system. MJ was launched on Dec 2, 2015 and is issued by Amplify Investments.
Top 10 Holdings
99.88% of assets| Name | Symbol | Weight |
|---|---|---|
| Amplify Seymour Cannabis ETF | CNBS | 44.80% |
| Tilray Brands, Inc. | TLRY | 12.95% |
| Cronos Group Inc. | CRON | 10.42% |
| SNDL Inc. | SNDL | 8.39% |
| Aurora Cannabis Inc. | ACB | 6.40% |
| Canopy Growth Corporation | WEED | 5.69% |
| High Tide Inc. | HITI | 4.28% |
| Village Farms International, Inc. | VFF | 3.27% |
| Organigram Global Inc. | OGI | 3.26% |
| Short-Term Investment Trust - Invesco Government & Agency Portfolio | AGPXX | 0.41% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2024 | $0.29001 | Dec 31, 2024 |
| Sep 27, 2024 | $0.71437 | Sep 30, 2024 |
| Jun 27, 2024 | $2.036 | Jun 28, 2024 |
| Mar 26, 2024 | $0.66903 | Mar 28, 2024 |
| Dec 27, 2023 | $0.6696 | Dec 29, 2023 |
| Sep 20, 2023 | $0.360 | Sep 22, 2023 |
Performance
MJ had a total return of -49.78% in the past year, including dividends. Since the fund's inception, the average annual return has been -33.05%.
News
MJ And MSOS: Cannabis' Inevitable Legalization Offers High Upside Despite Blunt Risks
Cannabis legalization is inevitable, driven by shifting political, generational, and fiscal dynamics, especially as Republicans seek votes and tax revenue. Despite high risks, the upside for cannabis ...
Amplify ETFs Aligns Global and U.S. Cannabis Exposure Across MJ and CNBS
CHICAGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Amplify ETFs announces the realignment of its cannabis ETFs to provide investors with dynamic exposure to the cannabis industry. On January 28, 2025, the Amp...
Cannabis stocks rally after Trump supports moving drug to less restrictive category
GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.
Amplify ETFs Declares June Income Distributions for its ETFs
CHICAGO, June 27, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announces June income distributions for its ETFs. ETF Name Ticker Amount per Share Ex-Date Record Date Payable Date Amplify AI Powered Equity ...
DEA to Reclassify Marijuana | Daily Stock Market Wrap 4/30
The stock market sank in the final stretch of April and bond yields climbed on concern that stubborn inflation will force the Federal Reserve to keep interest rates higher for longer. On the eve of th...
Biden administration to ease federal restrictions on marijuana
CNBC's Brandon Gomez joins 'Power Lunch' to discuss the Biden administration's plan to reclassify marijuana, easing federal restrictions.
Cannabis stocks rally as AP reports imminent rescheduling proposal by DEA
Cannabis stocks were up sharply on Tuesday on a report by the Associated Press that the U.S. Drug Enforcement Administration is poised to propose the lowering of cannabis to a Schedule III controlled ...
MJ: Over Diversified Cannabis ETF, But Still A Solid Pick
Amplify Alternative Harvest ETF offers diversified investments in Canadian cannabis stocks and U.S. multi-state operators. Catalysts such as a reduction in the Canadian excise tax, potential legalizat...
Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs
CHICAGO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- Amplify ETFs announced today it has completed its previously announced acquisition of ETF Managers Group (ETFMG) exchange-traded fund (ETF) assets, which con...
JD Henning Cautious About 2024, An Unusual Year For Market Considerations
JD Henning discusses his approach to the market and emphasizes the importance of timing and using momentum gauges to avoid major market downturns. Investing vs trading portfolios.
2024's Cannabis Investment Landscape: Top Marijuana ETFs to Consider
The cannabis industry is rapidly evolving, attracting attention from investors seeking long-term growth. As legalization spreads globally, marijuana stocks and ETFs (Exchange-Traded Funds) are becomin...
Finding The Long-Term Winners In The Cannabis Sector, December 2023 Update
This article attempts to assess and rank the relative growth potential of the separate competitors in the cannabis industry. Long-term trends show projected growth in the U.S., Canadian, and global ca...
MJ: Can't Get Off The Ground
Investing in the cannabis industry has been challenging due to volatility and lack of federal banking reform. ETFMG Alternative Harvest ETF offers diversified exposure to the cannabis space, but timin...
The Sustainability Of Cannabis Bull Run
The DEA is considering reclassifying cannabis from Schedule I to Schedule III, leading to a surge in cannabis stocks. Reclassification could lead to tax breaks, access to banking services, and more ef...
A key Marijuana financing bill moves forward in the U.S. Senate
Cannabis stocks are in focus after the Secure and Fair Enforcement Regulation Banking Act moved forward in the upper chamber of Congress on Wednesday. What the renegotiated SAFER means for cannabis co...
Cannabis stock rise as Senate committee OKs cannabis banking bill
Cannabis stocks moved up Wednesday after the U.S. Senate Committee on Banking, Housing and Urban Affairs approved the Secure and Fair Enforcement Regulation Banking Act, now known as the SAFER Banking...
Cannabis banking bill looks poised to get Senate committee's OK on Sept. 27
The Senate Banking Committee looks set to vote in a week and a half to advance a much-anticipated bill that aims to make it easier for the financial industry to work with cannabis companies.
Marijuana Watchlist: September 2023's Standout ETFs in Cannabis
In 2023, the cannabis industry and top marijuana stocks are blazing a trail of exponential growth, presenting investors with a unique opportunity to tap into this flourishing sector. As regulatory lan...
Cannabis ETFs boom as HHS recommendation to ease restrictions raises hopes for federal reform
Marijuana-related ETF's are trading higher in September after HHS recommended that the U.S. reclassify and ease restrictions on marijuana.
Cannabis stocks gain as banking bill finds traction in Senate, but House OK looks challenging
Cannabis stocks advanced Thursday, helped by news that a key Senate committee could soon vote to advance a widely followed bill that aims to make it easier for the financial industry to work with cann...
Possible cannabis reclassification fuels fund optimism
Possible cannabis reclassification fuels fund optimism.
HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain
The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many q...
U.S. Dept. of Health and Human Services recommends re-scheduling cannabis, as stocks in the sector rally
The U.S. Department of Health and Human Services is recommending to the U.S. Drug Enforcement Administration that cannabis should be reclassified as a Schedule III controlled substance under U.S. law ...